Health Care: Health Services

AcelRx Pharmaceuticals Inc (ACRX: NASDAQ)

$2.1 n/a | n/a%
06/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 17.36M 19.26M 5.22M 29.50M
Cost of Sales 10.25M 1.77M 0.00 0.00
Gross Operating Profit 7.11M 17.49M 5.22M 29.50M
Selling, General, and Administrative Expenses 15.60M 14.20M 18.35M 9.88M
Research & Development 21.40M 22.49M 24.52M 26.29M
Operating Income before D & A (EBITDA) -29.89M -19.20M -37.65M -6.67M
Depreciation & Amortization 2.07M 2.10M 1.08M 795.00K
Interest Income 918.00K 1.72M 6.93M 0.00
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -31.04M -20.33M -31.80M -7.46M
Interest Expense 12.15M 5.41M 2.64M 16.76M
Pre-Tax Income -43.19M -25.74M -34.44M -24.22M
Income Taxes -34.00K 760.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -43.16M -24.40M -33.35M -23.43M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -43.16M -24.40M -33.35M -23.43M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -43.16M -24.40M -33.35M -23.43M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-43.16M -23.64M -33.35M -23.43M
Preferred Dividends
Net Income Available To Common -43.16M -24.40M -33.35M -23.43M
Basic EPS from Continuing Ops. -0.95 -0.55 -0.77 -0.59
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.95 -0.55 -0.77 -0.59
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.95 -0.55 -0.77 -0.59
Basic Normalized Net Income/Share -0.95 -0.53 -0.77 -0.59
EPS fr Continuing Ops. -0.95 -0.60 -0.91 -0.59
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.95 -0.60 -0.91 -0.59
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.95 -0.60 -0.91 -0.59
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.95 -0.58 -0.91 -0.59
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACRX

Latest ACRX Headlines from TheStreet

More Financial News for ACRX

Press Releases for ACRX

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter